文献速递瓣膜外科

最佳与次优二尖瓣修复的匹配队列远期结果

Optimal versus suboptimal mitral valve repair: late results in a matched cohort study.
PubMed 文献 · Eur J Cardiothorac Surg · 2020-01-01

该匹配队列研究比较了退行性二尖瓣反流修复术后出院时残余反流>1+与≤1+患者的远期结局。中位随访8年,两组生存率和再手术率相似,但次优组8年MR≥3+比例显著更高且更多使用利尿剂、β受体阻滞剂和ACEI/ARB。即使初始结果最佳,退行性病变仍会逐渐进展。

要点

  • 出院时残余MR>1+与修复耐久性降低和远期更多药物治疗相关
  • 两组8年生存率和再手术率无显著差异
  • 即使初始修复结果最佳,退行性MR仍会逐渐进展

核心结论

  • 出院时残余MR超过轻度与二尖瓣修复耐久性降低及远期需要更多药物治疗相关。
  • 即使初始修复结果最佳,也不能完全阻止退行性病变的进展。

研究设计与样本

  • 匹配队列研究,纳入2006至2013年单中心2158例因退行性MR行二尖瓣修复的患者。
  • 中位随访8年(四分位距6.3-10.1,最长12.7年)。

主要发现

  • 8年总生存率研究组87±8%,对照组92±3%(P=0.23)。
  • 研究组远期死亡3例(6.0%),对照组6例(6.6%)。
  • 两组免于再手术率相似(P=1.0)。
  • 8年时MR≥3+的患病率研究组显著更高(15.6% vs 2.1%,P<0.001)。
  • 研究组利尿剂、β受体阻滞剂和ACEI/ARB的使用更多。

临床怎么用

  • 二尖瓣修复术后应努力达到残余MR≤1+,以保障远期耐久性。
  • 出院时残余MR>1+的患者需加强随访和药物治疗。
  • 即使修复结果最佳,也应长期监测MR进展。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: After mitral repair for degenerative mitral regurgitation (MR), no or mild (≤1+/4+) residual MR should remain. Occasionally patients are left with more than mild residual MR (>1+/4+) for a number of reasons. The aim of this study was to assess the late implications of such a suboptimal repair in a matched cohort study. METHODS: From 2006 to 2013, a total of 2158 patients underwent mitral repair for degenerative MR in our institution. Fifty patients (2.3%) with residual MR >1+ at hospital discharge (study group) were matched up to 1:2 with 91 patients operated on during the same period who were discharged with MR ≤1+ (control group). The median follow-up was 8 years (interquartile range 6.3-10.1, longest 12.7 years). A comparative analysis of the outcomes in the 2 groups was performed. RESULTS: Overall survival at 8 years was 87 ± 8% in the study group and 92 ± 3% in the control group (P = 0.23). There were 3 late deaths (6.0%) in the study group and 6 deaths (6.6%) in the control group. Freedom from reoperation was similar (P = 1.0). At 8 years the prevalence of MR ≥3+ was significantly higher in the study group (15.6% vs 2.1%, P < 0.001) as was the use of diuretics, beta-blockers and angiotensin-converting enzyme inhibitors/angiotensin-receptor blockers. Interestingly, even in the control group, a gradual progression of MR was observed because 13.3% of the patients had MR ≥2+ at 8 years with a significant increase over time (P < 0.001). CONCLUSIONS: Residual MR more than mild at hospital discharge is associated with lower durability of mitral repair and the need for more medical therapy in the long term. However, even an initial optimal result does not completely arrest the progression of the degenerative process.

来源:Eur J Cardiothorac Surg,查看原文。版权归原作者所有。

引用

  1. De Bonis M, Zancanaro E, Lapenna E, et al. Optimal versus suboptimal mitral valve repair: late results in a matched cohort study. Eur J Cardiothorac Surg. 2020. PMID: 32298423. doi:10.1093/ejcts/ezaa103

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。